Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.19639 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.3717 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.18323 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.10241 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.14285 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.23948 | 48 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.44646 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.15639 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1559 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.14679 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.15578 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.12908 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.26015 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.15187 | 49 |